PL343851A1 - Antihyperlipidemic statin-lp(a) inhibitor combinations - Google Patents
Antihyperlipidemic statin-lp(a) inhibitor combinationsInfo
- Publication number
- PL343851A1 PL343851A1 PL98343851A PL34385198A PL343851A1 PL 343851 A1 PL343851 A1 PL 343851A1 PL 98343851 A PL98343851 A PL 98343851A PL 34385198 A PL34385198 A PL 34385198A PL 343851 A1 PL343851 A1 PL 343851A1
- Authority
- PL
- Poland
- Prior art keywords
- antihyperlipidemic
- statin
- inhibitor combinations
- inhibitor
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6943297P | 1997-12-12 | 1997-12-12 | |
PCT/US1998/023480 WO1999030706A1 (en) | 1997-12-12 | 1998-11-04 | ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
PL343851A1 true PL343851A1 (en) | 2001-09-10 |
Family
ID=22088939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98343851A PL343851A1 (en) | 1997-12-12 | 1998-11-04 | Antihyperlipidemic statin-lp(a) inhibitor combinations |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1037623A1 (xx) |
JP (1) | JP2003524582A (xx) |
KR (1) | KR20010033017A (xx) |
AU (2) | AU1306099A (xx) |
BR (1) | BR9813539A (xx) |
CA (1) | CA2299397A1 (xx) |
HU (1) | HUP0100349A3 (xx) |
IL (1) | IL134364A0 (xx) |
IS (1) | IS5385A (xx) |
NO (1) | NO20002965L (xx) |
NZ (1) | NZ502874A (xx) |
PL (1) | PL343851A1 (xx) |
WO (1) | WO1999030706A1 (xx) |
ZA (1) | ZA9811349B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU739020B2 (en) | 1997-01-07 | 2001-10-04 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for the reduction of food intake |
EP1076091A1 (en) * | 1999-08-09 | 2001-02-14 | Universite Catholique De Louvain | Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
WO2001051078A1 (en) * | 2000-01-10 | 2001-07-19 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
EP1275388A4 (en) * | 2000-02-10 | 2003-11-26 | Takeda Chemical Industries Ltd | TNF ALPHA INHIBITORS |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2016467A1 (en) * | 1989-06-05 | 1990-12-05 | Martin Eisman | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
WO1993013801A1 (en) * | 1992-01-17 | 1993-07-22 | The Procter & Gamble Company | Treatment for atherosclerosis |
CA2129732A1 (en) * | 1992-02-25 | 1993-09-02 | Alain Martin | Cytoprotective compositions containing pyruvate and antioxidants |
US5720963A (en) * | 1994-08-26 | 1998-02-24 | Mary Kay Inc. | Barrier disruption treatments for structurally deteriorated skin |
US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
EP0738510A3 (fr) * | 1995-04-20 | 2005-12-21 | L'oreal | Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes |
EP0904082A4 (en) * | 1996-04-17 | 2001-09-26 | Merck & Co Inc | COMBINATION THERAPY TO REDUCE THE RISKS OF HEART CIRCULAR DISEASES |
NZ503982A (en) * | 1997-12-12 | 2002-03-28 | Warner Lambert Co | Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus |
-
1998
- 1998-11-04 KR KR1020007006370A patent/KR20010033017A/ko not_active Application Discontinuation
- 1998-11-04 BR BR9813539-2A patent/BR9813539A/pt not_active Application Discontinuation
- 1998-11-04 CA CA002299397A patent/CA2299397A1/en not_active Abandoned
- 1998-11-04 IL IL13436498A patent/IL134364A0/xx unknown
- 1998-11-04 EP EP98956562A patent/EP1037623A1/en not_active Ceased
- 1998-11-04 JP JP2000538689A patent/JP2003524582A/ja active Pending
- 1998-11-04 NZ NZ502874A patent/NZ502874A/en unknown
- 1998-11-04 WO PCT/US1998/023480 patent/WO1999030706A1/en not_active Application Discontinuation
- 1998-11-04 HU HU0100349A patent/HUP0100349A3/hu unknown
- 1998-11-04 AU AU13060/99A patent/AU1306099A/en not_active Abandoned
- 1998-11-04 PL PL98343851A patent/PL343851A1/xx unknown
- 1998-12-10 ZA ZA9811349A patent/ZA9811349B/xx unknown
-
2000
- 2000-02-25 IS IS5385A patent/IS5385A/is unknown
- 2000-06-09 NO NO20002965A patent/NO20002965L/no not_active Application Discontinuation
-
2003
- 2003-08-29 AU AU2003244047A patent/AU2003244047A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP0100349A2 (hu) | 2001-07-30 |
HUP0100349A3 (en) | 2002-02-28 |
AU1306099A (en) | 1999-07-05 |
CA2299397A1 (en) | 1999-06-24 |
NZ502874A (en) | 2004-03-26 |
ZA9811349B (en) | 1999-06-14 |
NO20002965D0 (no) | 2000-06-09 |
KR20010033017A (ko) | 2001-04-25 |
EP1037623A1 (en) | 2000-09-27 |
IL134364A0 (en) | 2001-04-30 |
IS5385A (is) | 2000-02-25 |
AU2003244047A1 (en) | 2003-09-25 |
BR9813539A (pt) | 2000-10-10 |
WO1999030706A1 (en) | 1999-06-24 |
NO20002965L (no) | 2000-06-09 |
JP2003524582A (ja) | 2003-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9608062D0 (en) | A Case | |
TW370014U (en) | A drawing board | |
AU137878S (en) | A tray | |
PL343851A1 (en) | Antihyperlipidemic statin-lp(a) inhibitor combinations | |
GB9704222D0 (en) | A component | |
GB9724237D0 (en) | A tray | |
AU134857S (en) | A table | |
GB9717959D0 (en) | A holdall | |
AU129623S (en) | A hammer | |
AU133796S (en) | A board | |
GB9721943D0 (en) | A component | |
AU135771S (en) | A switch | |
IL120253A0 (en) | A screw - wrench | |
GB9712190D0 (en) | A book-end | |
GB9715367D0 (en) | A dredgehead | |
AU135496S (en) | A crumpet | |
AU133234S (en) | A teapot-container | |
AU132788S (en) | A pareo | |
AU132787S (en) | A pareo | |
AU129522S (en) | A time piece | |
ZA988491B (en) | A time piece | |
AU129626S (en) | A time piece | |
GB2329868B (en) | A tray | |
TW334965U (en) | A hand-cart structure (II) | |
GB2328796B (en) | A switch |